Target intelligence / Profile preview

Max dimerization protein 4 (MXD4)

Target
MXD4
Molecular classification
Transcription factor, Basic helix-loop-helix-leucine zipper (bHLH-LZ) protein, Max dimerization protein family
01

Overview

Max dimerization protein 4 (MXD4) is a transcriptional repressor that forms heterodimers with the MAX protein, enabling it to bind DNA at E-box sequences and repress transcription of target genes. MXD4 competes with MYC for binding to MAX; whereas MYC/MAX heterodimers activate transcription and drive cell proliferation, MXD4/MAX heterodimers repress MYC target genes, antagonizing MYC function and promoting cell differentiation or quiescence. Studies indicate that MXD4 acts as a tumor suppressor and is involved in regulating the balance between cell proliferation and differentiation. Aberrant expression or genetic alteration of MXD4 has been associated with human cancers, such as NUTM1-rearranged sarcomas and acute myeloid leukemia, where it modulates the MYC transcriptional network and impacts self-renewal and tumorigenesis. MXD4 belongs to the basic helix-loop-helix-leucine zipper (bHLH-LZ) family of transcription factors and is classified as a Max dimerization (MAD/MXD) protein.

Other names
MAD4BHLHC12MSTP149MST149bHLHc12Max-interacting transcriptional repressor MAD4Max-associated protein 4Class C basic helix-loop-helix protein 12
02

Biological functions

Regulation of transcription (transcriptional repressor)Negative regulation of MYC activityCell differentiationTumor suppressionCell cycle regulation
03

Disease associations

Cancer (tumor suppressor function, involvement in leukemogenesis and certain sarcomas)Role in modulation of MYC-driven cancers

Beyond the preview

Go deeper on Max dimerization protein 4 (MXD4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Max dimerization protein 4 (MXD4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call